Roger...great points. Steelers, Bills, Jags and Cowboys round out the first 4 games absent Brady.
If suspension holds, Patriots could start out 2 and 2...some impact.
How incredible as it may sound a recent news report noted that in view of the highly successful LO/RAI merger, an MO/PM merger (putting Humpy Dumpty back together again) is not out of the question,
The report noted that the catalyst is neither PM or MO, but BTI (British American Tobacco) which owns 42% or so of the new RAI company. BTI competes directly vs. PM in the international markets; BTI now owns an domestic component in RAI; PM has no domestic component.
Just saying....... not that far out of the box.
The klongturd gets slapped down again, LOL
Reply to Are we halted - approved for high rish patients - by k1ltnow •Jun 10, 2015 4:42 PM
stevedavis811 • Jun 10, 2015 5:21 PM Flag
You have mental problem. You need to see a shrink. Go back to AAPL, PM, GILD, C, BAC, AIG, WFC etc and pollute those boards.
LONDON—British American Tobacco PLC on Wednesday reported higher first-half profit as the cigarette-maker was buoyed by investments that helped offset currency losses.
This ADR can be played as a supplementary investment to RAI. BTI holdings represent a 42% share ownership of RAI.
Disclosure long BTI
Friend of mine posting over at the AMGN board noted that Klongturd (referred to as a complete moron) lost his draws on several AMGN trades. Just proves our theory on the Klongturd investment theory "BUY HIGH SELL LOW".....LOL
by stevedavis811 • Jun 10, 2015 5:35 PM Flag
What happened to all the old members of this board such as Steve Silverman, Shade of Pale and many more.
Those were the days when we used to get real info about AMGN. This was in !990's. NOW we have idiots like K1ltnow, a complete moron. Steve and Shade owned AMGN since inception in early eighties. I was a late comer, my average is about 40. I would like to hear from them. If you guys are watching, please give us your guidance.
Thanks for that. Going from one great stock (LO) to another (RAI).
Yes, I like it all as well.
Earnings: RAI posts higher than expected earnings. Our consensus earnings estimate called for EPS of $0.94/share, and the company’s reported EPS was $1.02/share. Investors should note that these figures take out stock option expenses.
Revenues: RAI reported revenues of $2.40 billion. This missed our consensus estimate of $2.71 billion.
Key Stats to Note: Operating Income increased 19.2% year over year.
Reynolds announced a dividend increase of 7.5% and two-for-one stock split.
Gilead Sciences (GILD) reports its FQ2 ’15 results after the closing bell tomorrow. Both Estimize and Wall Street are predicting a fall in EPS and revenues QoQ. Estimize are forecasting an EPS figure of $2.77 and a revenue target of $7.540B. Wall Street estimates EPS to come in at $2.64 and revenues to be $7.360B.
Despite the potential negatives associated with falling revenue growth, Gilead is in a very strong position in terms of its balance sheet. Gilead has the ability to use its balance sheet to its advantage and potentially acquire desirable businesses in an attempt to bolster growth over the coming years. However, Gilead’s management have informed the market that they will not rush into a transaction and pay too much to acquire another company. In February, Gilead announced to the market that they will start paying a $0.43 quarterly dividend and launch a $15B share buyback program. Importantly, the market has previously rewarded drug makers engaging in M&A activity. Companies such as AbbVie (ABBV) and Alexion Pharmaceuticals (ALXN) have both benefited from their M&A strategies and are both trading at considerable premiums since their acquisition announcements. These success stories place more pressure on Gilead’s management to act sooner rather than later with respect to making acquisitions.
Klongturd is a clown who hangs out on Yahoo Boards including PM.
He lost a ton of money investing poorly; example GORO , IBM just to mention a few..
He is the Pee we Herman of investing not to be taken seriously but always there for a good laugh....lol
As usual weaker hands selling precious shares to the shrewd market makers. Lessons never learned; we have several of those types on this board.
GILD returning to higher levels. What's not to like about GILD. A prize trophy in one's portfolio.
Reported earnings will test the GS call which placed RAI on their conviction buy list.
New all time of $81.00 was the GS call, I remain bullish.
k1ltnow • 21 hours ago Flag
"Tuesday going to be bad - we all know HEP C sales are lower then"
What a clown. So sell GILD if you are negative.....Buy high and sell low....LO